Ralf Halbach

General Manager | Pharma & MedTech | Driving Growth, Turnarounds & M&A | P&L & Commercialization Leader | Oncology, Diagnostics, Market Access | Private Equity | INSEAD MBA

Zug, Zug, Switzerland

About

Senior pharma and medtech executive with 25+ years of experience in general management, P&L leadership, and global commercialization. I have built and scaled organizations across Europe, the US, Asia, and Africa, consistently delivering growth, operational excellence, and cultural transformation. Fluent in six languages and with a PhD in Organic Chemistry plus an MBA from INSEAD, I bring both scientific credibility and commercial acumen to every leadership role. • General Management: Country and regional leadership, operational excellence, turnaround execution. • Commercialization: Brand launches, lifecycle management, and salesforce effectiveness. • Regulatory & Market Access: Direct engagement with FDA, EMA, MHRA, and health authorities worldwide. • International Leadership: Fluent in 5 languages, with deep experience in diverse cultural and regulatory environments. My track record includes achieving double-digit sales growth in developed & emerging markets, executing successful turnarounds in underperforming affiliates, and driving strategic M&A and portfolio diversification to strengthen competitiveness. I have overseen P&Ls up to CHF 400m, led teams of 800+, and delivered strong results in market access, product launches, and business transformation. Strong background in Oncology, Specialty Care, Rare Diseases. I am passionate about building high-performing, cross-cultural teams, developing strategies that accelerate growth, and ensuring long-term value creation for both patients and shareholders. Contact details: [email protected]

Experience

  • Client Service Partner at a-connect
    Jan 2026 - Present · 6 mos

  • Advisory Board at Numenos AI
    Jun 2025 - Present · 1 yr 1 mo

    Numenos AI is a tech-bio company that applies AI-driven foundation models to analyze clinico-genomic and real-world clinical data, enabling faster and more efficient drug discovery, patient stratification, and biomarker differentiation for the pharmaceutical industry.

  • Board Member at Cerhum
    Mar 2025 - Present · 1 yr 4 mos

    Cerhum is a Belgian medical device company based in Liège, specializing in the development and manufacturing of patient-specific, 3D-printed bioceramic implants for maxillofacial surgery.

  • Operating Advisor at Klutch Capital
    Aug 2024 - Present · 1 yr 11 mos

    As an Operating Advisor at Klutch Capital, I bridge investors and operators by helping leadership teams optimize processes, strengthen execution, and create long-term enterprise value.

  • Partner / Senior Advisor at InterPharmaLink AG
    Aug 2024 - Dec 2025 · 1 yr 5 mos

    Leading transaction & business advisory firm serving global healthcare companies, service providers, and investors. Expertise in M&A, partnering, operational improvement, and quality and sustainability. • Advised CDMO (API and FDF) with significant quality and efficiency issues: Conducted a Gap Assessement and outlined major deficiencies. Prepared a remediation plan and supported its implementation. • Advised buy-side Private Equity Firm with TechOPs due diligence of large, global CDMO. Assessement of technical operations of key production sites, R&D Program and supply chain.